Document is current
Any future updates will be listed below
-
Authors
Sonsalla, Michelle M.
Babygirija, Reji
Johnson, Madeline
Cai, Samuel
Cole, Mari
Yeh, Chung-Yang
Grunow, Isaac
Liu, Yang
Vertein, Diana
Calubag, Mariah F.
Trautman, Michaela E.
Green, Cara L.
Rigby, Michael J.
Puglielli, Luigi
Lamming, Dudley W. https://orcid.org/0000-0002-0079-4467
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 31 August 2024
First Online: 14 September 2024
Declarations
:
: DWL has received funding from, and is a scientific advisory board member of, Aeovian Pharmaceuticals, which seeks to develop novel, selective mTOR inhibitors for the treatment of various diseases.
